New drug combo targets Hard-to-Treat cancers
NCT ID NCT05417594
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 32 times
Summary
This study is testing a new drug called AZD9574, either alone or with other cancer medicines, in people with advanced solid tumors that have grown or come back after standard treatments. The main goals are to check the drug's safety, how the body processes it, and whether it can shrink tumors. About 695 participants will take part in this early-phase trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
WITHDRAWNHeidelberg, 69120, Germany
-
Research Site
WITHDRAWNMainz, 55131, Germany
-
Research Site
RECRUITINGSeoul, 03080, South Korea
-
Research Site
RECRUITINGSeoul, 03722, South Korea
-
Research Site
RECRUITINGSeoul, 06351, South Korea
-
Research Site
RECRUITINGA Coruña, 15006, Spain
-
Research Site
RECRUITINGBarcelona, 8035, Spain
-
Research Site
RECRUITINGMálaga, 29010, Spain
-
Research Site
RECRUITINGPozuelo de Alarcón, 28223, Spain
-
Research Site
RECRUITINGSant Cugat del Vallès, 08195, Spain
-
Research Site
RECRUITINGSeville, 41013, Spain
-
Research Site
RECRUITINGLund, 22185, Sweden
-
Research Site
RECRUITINGStockholm, 118 83, Sweden
-
Research Site
RECRUITINGGlasgow, Scotland, G12 0YN, United Kingdom
-
Research Site
RECRUITINGLondon, EC1M 6BQ, United Kingdom
-
Research Site
RECRUITINGNewcastle upon Tyne, NE7 7DN, United Kingdom
-
Research Site
WITHDRAWNBayern, 80337, Germany
-
Research Site
WITHDRAWNBerlin, 13353, Germany
-
Research Site
WITHDRAWNLa Jolla, California, 92093, United States
-
Research Site
RECRUITINGLos Angeles, California, 90095, United States
-
Research Site
RECRUITINGSan Francisco, California, 94143, United States
-
Research Site
RECRUITINGChicago, Illinois, 60611, United States
-
Research Site
RECRUITINGBoston, Massachusetts, 02215, United States
-
Research Site
RECRUITINGNew York, New York, 10040, United States
-
Research Site
RECRUITINGNew York, New York, 10065, United States
-
Research Site
COMPLETEDPortland, Oregon, 97239, United States
-
Research Site
RECRUITINGHouston, Texas, 77030, United States
-
Research Site
NOT_YET_RECRUITINGSan Antonio, Texas, 78229, United States
-
Research Site
WITHDRAWNRichmond, Virginia, 23298, United States
-
Research Site
RECRUITINGDarlinghurst, 2010, Australia
-
Research Site
RECRUITINGMelbourne, 3000, Australia
-
Research Site
RECRUITINGRandwick, 2031, Australia
Conditions
Explore the condition pages connected to this study.